Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration

International Journal of Molecular Sciences(2021)10.3390/ijms22094672Source: DataRank Database

Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.95)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Lauren K. Wareham ORCID,Michael L. Risner ORCID,David J. Calkins ORCID,Sara Al Hussein Al Awamlh ORCID

Live enrichment

PubMed:33925119 PMC:PMC8124776 OpenAlex:https://openalex.org/W3159736999

National Institutes of Health

Grant: EY017427, EY024997, EY008126

National Institutes of Health

Grant: 5P30EY008126-08

CORE--ILLUSTRATION AND PHOTOGRAPHY MODULE

National Institutes of Health

Grant: 5R01EY024997-04

Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma

National Institutes of Health

Grant: 5R01EY017427-03

Transient Receptor Potential Channels and Retinal Ganglion Cell Death in Glaucoma

FWCI

3.95

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/22/9/4672/pdf?version=1620296243

publisherhttps://www.mdpi.com/1422-0067/22/9/4672/pdf?version=1620296243

publisherhttps://www.mdpi.com/1422-0067/22/9/4672/pdf

journalhttps://doi.org/10.3390/ijms22094672

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33925119

Fields of Study

Glaucoma and retinal disordersNeurological Disorders and TreatmentsRetinal Development and Disorders0301 basic medicine03 medical and health sciences

MeSH Terms

NeuroprotectionAnimalsDisease Models, AnimalGlaucomaHumansInsulinRetinaRetinal Ganglion CellsSignal TransductionNeurodegenerative DiseasesMolecular Targeted Therapy

Keywords

NeurodegenerationNeuroprotectionNeuroscienceInsulin receptorInsulinBiologyRetinaGlaucomaMedicineDiseaseInternal medicineEndocrinologyInsulin resistanceCNSRgcPi3k/aktRetinal Ganglion CellsNeurodegenerative DiseasesReviewDisease Models, AnimalAnimalsHumansMolecular Targeted TherapySignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)